Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irvin M Modlin

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Gastroenterology|September 16, 2008
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux diseasePeter J Kahrilas, Nicholas J Shaheen, Michael F Vaezi, et al.
International Journal of Medical Sciences|April 16, 2021
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasmsAndrea Frilling, Ashley K Clift, Adam E Frampton, et al.
Endocrine Connections|January 21, 2017
Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systemsAshley K Clift, Omar Faiz, Robert Goldin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
Journal of Thoracic Disease|December 5, 2017
Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasmsIrvin M Modlin, Mark Kidd, Pier-Luigi Filosso, et al.
Surgery|October 13, 2015
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategiesIrvin M Modlin, Andrea Frilling, Ronald R Salem, et al.
The Lancet. Oncology|January 4, 2014
Recommendations for management of patients with neuroendocrine liver metastasesAndrea Frilling, Irvin M Modlin, Mark Kidd, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2018
PRRT genomic signature in blood for prediction of <sup>177</sup>Lu-octreotate efficacyLisa Bodei, Mark S Kidd, Aviral Singh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2019
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETestLisa Bodei, Mark S Kidd, Aviral Singh, et al.
Digestion|July 11, 2003
GERD 2003 -- a consensus on the way aheadSteven F Moss, David Armstrong, Rudi Arnold, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Gastroenterology|September 16, 2008
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux diseasePeter J Kahrilas, Nicholas J Shaheen, Michael F Vaezi, et al.
International Journal of Medical Sciences|April 16, 2021
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasmsAndrea Frilling, Ashley K Clift, Adam E Frampton, et al.
Endocrine Connections|January 21, 2017
Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systemsAshley K Clift, Omar Faiz, Robert Goldin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
Journal of Thoracic Disease|December 5, 2017
Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasmsIrvin M Modlin, Mark Kidd, Pier-Luigi Filosso, et al.
Surgery|October 13, 2015
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategiesIrvin M Modlin, Andrea Frilling, Ronald R Salem, et al.
The Lancet. Oncology|January 4, 2014
Recommendations for management of patients with neuroendocrine liver metastasesAndrea Frilling, Irvin M Modlin, Mark Kidd, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2018
PRRT genomic signature in blood for prediction of <sup>177</sup>Lu-octreotate efficacyLisa Bodei, Mark S Kidd, Aviral Singh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2019
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETestLisa Bodei, Mark S Kidd, Aviral Singh, et al.
Digestion|July 11, 2003
GERD 2003 -- a consensus on the way aheadSteven F Moss, David Armstrong, Rudi Arnold, et al.
Pageof 15